Nuacht

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
FDA expands COVID vaccine warning about possible side effect
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...
What to know about the FDA plan to restrict COVID vaccines
In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only ...
FDA announces plans to restrict access for COVID vaccines
For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.
FDA’s new approach raises questions about fall COVID vaccine availability
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
WA vaccine scientists push back against FDA changes around COVID shots
Seattle vaccine experts were confused by the country's apparent new direction around updated COVID-19 shots, which top FDA ...
FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Health on MSN7 uair an chloig
FDA to Limit Access to COVID Vaccines—What This Means For You
The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...